ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,464Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 670

$505K Total Retail Price of All Prescriptions

Rank: 184 out of 670

296 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 296 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 296 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 545 407 S3 1 1
LEVOTHYROXINE SODIUM 511 415 2 2
PRAVASTATIN SODIUM 330 283 3 19
OMEPRAZOLE 290 251 4 5
FUROSEMIDE 249 213 5 6
METFORMIN HCL 205 199 6 8
DONEPEZIL HCL 173 166 7 31
WARFARIN SODIUM 165 138 8 13
AMLODIPINE BESYLATE 164 147 9 7
METOPROLOL TARTRATE 164 139 9 9
METOPROLOL SUCCINATE 162 146 11 12
POTASSIUM CHLORIDE 161 129 12 16
SIMVASTATIN 157 140 13 4
FAMOTIDINE 151 126 14 99
ZOLPIDEM TARTRATE 132 97 15 23
DILTIAZEM 24HR CD 132 128 15 109
GABAPENTIN 132 92 15 11
LISINOPRIL 132 118 15 3
CITALOPRAM HBR 119 116 19 20
AZITHROMYCIN 119 101 19 35
NAMENDA 118 115 21 54
JANUVIA 118 112 21 53
HYDRALAZINE HCL 118 103 21 147
ADVAIR DISKUS 115 87 24 42
DOXYCYCLINE HYCLATE 110 84 25 132
ALENDRONATE SODIUM 109 107 26 43
NAPROXEN 104 59 27 81
HYDROCHLOROTHIAZIDE 99 77 28 10
LOSARTAN POTASSIUM 94 71 29 26
CLONIDINE HCL 93 92 30 62
ALLOPURINOL 84 71 31 38
ATORVASTATIN CALCIUM 83 73 32 15
CRESTOR 81 45 33 18
TRIAMTERENE-HYDROCHLOROTHIAZID 75 61 34 172
CIPROFLOXACIN HCL 75 57 34 60
LOSARTAN-HYDROCHLOROTHIAZIDE 75 66 34 73
TORSEMIDE 74 54 37 100
NEXIUM 72 37 38 14
RISPERIDONE 72 72 38 80
TRAMADOL HCL 70 45 40 21
TAMSULOSIN HCL 69 35 41 30
SYNTHROID 65 65 42 47
TRIAMTERENE-HCTZ 65 53 42 69
ESCITALOPRAM OXALATE 64 59 44 78
SINGULAIR 60 37 45 56
CLOPIDOGREL 59 49 46 24
OXYBUTYNIN CHLORIDE ER 56 55 47 148
POLYETHYLENE GLYCOL 3350 55 42 48 79
TRAMADOL HCL-ACETAMINOPHEN 54 54 49 211
DILTIAZEM HCL 53 46 50 204
SERTRALINE HCL 52 32 51 22
MECLIZINE HCL 52 51 51 114
FENTANYL 52 37 S2 51 76
MELOXICAM 51 47 54 33
SPIRONOLACTONE 51 39 54 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.